A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity

BACKGROUND: Liver cancer, of which hepatocellular carcinoma (HCC) is by far the most common type, is the second most deadly cancer (746,000 deaths in 2012). Currently, the only curative treatment for HCC is surgery to remove the malignancy (resection) or to remove the entire diseased liver followed...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qing Yan, Almudevar, Anthony, Whitney-Miller, Christa L., Barry, Christopher T., McCall, Matthew N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826548/
https://www.ncbi.nlm.nih.gov/pubmed/27059462
http://dx.doi.org/10.1186/s12920-016-0179-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826548/
https://www.ncbi.nlm.nih.gov/pubmed/27059462
http://dx.doi.org/10.1186/s12920-016-0179-4

Ejemplares similares